ProQR Therapeutics Cash from Financing (TTM) Trends

ProQR Therapeutics NV (PRQR)

2.01 +0.02 (+1.00%) USD | NASDAQ | May 03, 16:00

2.02 +0.01 (+0.50%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	-2.463M
September 30, 2023	11.12M
June 30, 2023	-32.60M
March 31, 2023	-32.25M
December 31, 2022	-32.58M
September 30, 2022	-12.65M
June 30, 2022	56.90M
March 31, 2022	157.69M
December 31, 2021	161.90M
September 30, 2021	129.40M
June 30, 2021	119.44M
March 31, 2021	19.54M
December 31, 2020	16.56M
September 30, 2020	72.93M
June 30, 2020	57.04M
March 31, 2020	56.27M
December 31, 2019	56.20M
September 30, 2019	2.684M
June 30, 2019	101.88M

Date	Value
March 31, 2019	102.26M
December 31, 2018	102.09M
September 30, 2018	118.86M
June 30, 2018	27.04M
March 31, 2018	28.25M
December 31, 2017	30.17M
September 30, 2017	10.91M
June 30, 2017	3.850M
March 31, 2017	2.484M
December 31, 2016	0.3951M
September 30, 2016	0.6195M
June 30, 2016	0.6308M
March 31, 2016	2.010M
December 31, 2015	1.798M
September 30, 2015	2.120M
June 30, 2015	106.63M
March 31, 2015	159.44M
December 31, 2014	159.42M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-32.60M

Minimum

Jun 2023

161.90M

Maximum

Dec 2021

47.74M

Average

56.20M

Median

Dec 2019

Cash from Financing (TTM) Benchmarks